QUE Oncology is developing drugs for large unmet medical needs and has already advanced clinical development of its lead drug program Q-122, through four Phase 1 trials. QUE
The post QUE Oncology launches phase 2 trials in the US appeared first on Pharmaceutical Business review.
Original Article: QUE Oncology launches phase 2 trials in the US